Since closing the question about GSK’s corporate citizenship last year, the Third Circuit opened the narrower question about where the remaining cases over its antidepressant drug Paxil would be heard. That issue was before the appeals court Wednesday.
Last year, the U.S. Court of Appeals for the Third Circuit held that GlaxoSmithKline is a corporate citizen of Delaware, not Pennsylvania, which effectively preserved GSK’s ability to remove to federal court cases filed against it in Pennsylvania state courts.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
